scispace - formally typeset
A

Anthony B Cardillo

Researcher at University of Rochester Medical Center

Publications -  8
Citations -  28

Anthony B Cardillo is an academic researcher from University of Rochester Medical Center. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 3 publications receiving 6 citations.

Papers
More filters
Posted ContentDOI

A multiplex microsphere IgG assay for SARS-CoV-2 using ACE2-mediated inhibition as a surrogate for neutralization.

TL;DR: A multiplex fluorescent microsphere-based assay that can detect antibodies to three SARS-CoV-2 antigens-spike (S) protein, the spike ACE2 receptor-binding domain (RBD), and nucleocapsid (NP) that proved adaptable to the emergence of a novel infectious agent.
Posted ContentDOI

Validation and clinical discovery demonstration of a real-world data extraction platform

TL;DR: In this paper , clinical variables were extracted from the medical records of consented patients with metastatic breast cancer, and case report forms completed using the structured data output of the platform were compared to manual chart review for 50 patients.
Journal ArticleDOI

Abstract 4088: A novel real world clinico-genomics data platform identifies breast cancer histologic and molecular characteristics as candidate predictors for time to distant metastasis

TL;DR: How tumor histologic and molecular characteristics analyzed from a real-world data platform correlate with the average time to distant recurrence can guide more personalized surveillance for invasive breast cancer patients is reported.
Journal ArticleDOI

Exploration of HER2 (ERBB2) immunohistochemistry in non-small cell lung cancer: correlation with ERBB2 mutational status: experimental research

TL;DR: In this paper , the authors retrieved cases of lung adenocarcinoma with next-generation sequencing proven ERBB2 point mutations (n=8) or amplifications (n = 11) and assessed the concordance of commercially available HER2 (HER2) immunohistochemical antibodies with the next generation sequencing result.